Latest Regulatory Approval News

Advanced Innergy Solutions has completed its acquisition of Matrix Composites & Engineering via a members’ scheme, paying shareholders 40 cents per share and moving to delist the company from the ASX by 24 July 2026.

OZZ Resources moves closer to acquiring Sulphide Minerals and regaining ASX listing with a $5 million capital raise, while navigating legal challenges on key tenements.

Manhattan Gold Corporation has kicked off its first modern drilling in over 30 years at Nunavut’s Hook Lake Project, backed by expanded mineral rights and promising high-grade gold assays from surface sampling.

Australian Rare Earths (ASX: AR3) has uncovered a 10-kilometre magnetic anomaly at its Overland Project, significantly broadening its niobium-rare earth element drill targets beyond the initial OV167 discovery. Historic drill data supports the potential for a large-scale carbonatite system, prompting a new drilling campaign to test multiple priority targets.

Santos Limited edged up production by 3% in Q2 2026, with Barossa hitting 97% of planned output and Pikka phase 1 moving toward plateau. Sales revenue rose 6% to $1.35 billion, while free cash flow impacts from commissioning are expected to reverse in H2.

Artrya has launched its AI-powered Salix platform at Northeast Georgia Health System, marking its second U.S. commercial customer with active revenue streams from subscription and fee-per-scan models.

Patronus Resources has kicked off its 2026 exploration season with promising high-grade gold results at the Tally Ho deposit in the Northern Territory and secured full ownership of the Guppy prospect in Western Australia, while executing a strategic uranium rights sale.

Eden Innovations has secured robust validation from India’s Central Road Research Institute showing its EdenCrete®Pz7 carbon nanotube admixture boosts concrete strength, durability, and sustainability in key infrastructure mixes.

Spenda Limited anticipates a significant R&D tax offset exceeding AUD 1.75 million for FY26, providing a timely cash boost amid its push towards cash-flow neutrality.

Alurion Resources has closed its IPO at the maximum subscription of A$50 million, setting the stage for an expanded development program at its Amargosa Bauxite-Gallium Project. Brazilian Rare Earths retains a strategic 16% stake as Alurion prepares for ASX listing.

Beach Energy delivered a solid FY26 with 19.4 MMboe production, a record 18 months without injuries, and a key Otway Basin asset sale freeing $500 million capital.

Cambium Bio has raised just over A$1 million through a strategic placement at a 17% premium, boosting a key shareholder’s stake as it advances its pivotal Phase 3 trial for dry eye disease.